Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback